Tempus AI's 10% dip reveals an opportunity as Q2 estimates are poised to exceed expectations, fueled by strong deals and ...

Tempus AI's growth is fueled by data services and acquisitions, despite financial risks. Key Q2 results may shape its path to ...

Deep 6’s platform strengthens Tempus AI’s provider connectivity, now totaling over 4,000 connections, and facilitates the two-way exchange of clinical and molecular data.

Tempus AI is a growth stock that is down 31% from all-time highs. Here's why TEM AI stock could be a part of your TFSA portfolio right now.

Shares of Tempus AI (NASDAQ: TEM) soared on Monday. The company's stock jumped 15% as of market close. The spike comes as the S&P 500 (SNPINDEX: ^GSPC) and the Nasdaq Composite (NASDAQINDEX: ^IXIC ...

Tempus AI (NASDAQ: TEM), a healthcare technology company, posted impressive Q1 results with revenue reaching $255.7 million, up 75.4% year-over-year. Adjusted EBITDA improved significantly to $-16 ...

On May 16, 2025, Tempus AI, Inc. (NASDAQ:TEM) stock closed at $65.49 per share with a market capitalization of $11.337 billion. Baron Discovery Fund stated the following regarding Tempus AI, Inc ...

Over the past year, shares of Tempus AI and Butterfly Network have surged 55.4% and 114.8%, respectively, handily outperforming the broader Medical Info Systems industry’s 13.6% gain and the S&P ...

The company's stock jumped 15% as of market close. The spike comes as the S&P 500 (SNPINDEX: ^GSPC) and the Nasdaq Composite (NASDAQINDEX: ^IXIC) jumped 0.4% and 0.6%, respectively. Tempus, a ...

June 02, 2025 — 05:22 pm EDT Written by Johnny Rice for The Motley Fool -> Shares of Tempus AI (NASDAQ: TEM) soared on Monday. The company's stock jumped 15% as of market close.